Osaka Univ. Team Develops Immune Cell Therapy for AML
Osaka, May 8 (Jiji Press)--A group of researchers at Japan's University of Osaka has developed a new immune cell therapy that could be applied to patients of acute myeloid leukemia, or AML, a type of hematological cancer. Many AML patients die of cancer recurrence even after receiving bone marrow transplants and other treatments. The new therapy could save such patients once it is put into p...
Tomas Kauer - News Moderator 
Osaka, May 8 (Jiji Press)--A group of researchers at Japan's University of Osaka has developed a new immune cell therapy that could be applied to patients of acute myeloid leukemia, or AML, a type of hematological cancer. Many AML patients die of cancer recurrence even after receiving bone marrow transplants and other treatments. The new therapy could save such patients once it is put into p...
